GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 7,570.00
+90.00 (1.20%)
Apr 14, 2026, 2:25 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 176.91 billion as of April 13, 2026.
Market Cap
176.91B
Enterprise Value
140.81B
Revenue
31.53B
Ranking
n/a
PE Ratio
40.43
Stock Price
7,570.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 176.91B, a decrease of -32.61%. That is a compound annual growth rate of -37.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 175.25B | 8.65% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.72T |
| Celltrion | 43.67T |
| ALTEOGEN | 19.34T |
| Samsung Epis Holdings | 13.61T |
| Vaxcell-Bio Therapeutics | 182.34B |
| REYON Pharmaceutical | 181.58B |
| MedPacto | 177.20B |
| Macrogen | 175.41B |